Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis

Hepatitis Monthly

Volumn 13, Issue 8, 2013, Pages 2-

  Keyvani, Hossein ^a   Bokharaei Salim, Farah ^a   Monavari, Seyed Hamidreza ^a   Esghaei, Maryam ^a   Toosi, Mohssen Nassiri ^b   Fakhim, Shahin ^c   Sadigh, Zohreh Azita ^d   Alavian, Seyed Moayed ^e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d Razi Vaccine Serum Production and Research Institute   (Iran)

^e Baqiyatallah Research Center for Gastroentrology and Liver Disease   (Iran)

Author keywords

Cirrhosis; Cryptogenic; Hepatitis; Liver transplantation; Occult infection; Peripheral blood mononuclear cells; Virus

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; LIVER GRAFT; MALE; NEIGHBOR JOINING METHOD; NUCLEOTIDE SEQUENCE; OCCULT BLOOD; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 84883195844     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.11290     Document Type: Article

References (36)

1. Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ. 1977;55(4):521-40.
2. Czaja AJ. Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults. Dig Dis Sci. 2011.
3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29(3):664-9.
4. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017-44.
5. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981;282(6260):263-6.
6. Belle SH, Beringer KC, Detre KM. An update on liver transplanta-tion in the United States: recipient characteristics and outcome. Clin Transpl. 1995:19-33.
7. Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg. 1997;3(4):359-64.
8. Desai HG. Cryptogenic cirrhosis: a vanishing entity. J Assoc Physicians India. 2009;57:751-4.
9. Al-Mahtab M, Rahman S, Khan M. Occult Hepatitis B Virus Related Decompensated Cirrhosis of Liver in Young Males: First Report of Two Cases from Bangladesh. Hepatitis Monthly. 2008;8(2):147-50.
10. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44(1):20-9.
11. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C Infection in the General Population of Iran: A Systematic Review. Hepat Mon. 2009;9(3):211-23.
12. Pham TN, Michalak TI. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol. 2008;14(18):2789-93.
13. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liverfunction tests is unknown. J Infect Dis. 2004;189(1):7-14.
14. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012;18(23):2887-94.
15. Bokharaei Salim F, Keyvani H, Amiri A, Jahanbakhsh Sefidi F, Shakeri R, Zamani F. Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol. 2010;16(16):2005-9.
16. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernandez N, et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol. 2008;19(12):2288-92.
17. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011;83(6):989-95.
18. Farahani M, Bokharaei-Salim F, Ghane M, Basi A, Meysami P, Keyvani H. Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders. J Med Virol. 2013;85(2):235-40.
19. Schiano TD, Martin P. Management of HCV infection and liver transplantation. Int J Med Sci. 2006;3(2):79-83.
20. Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest. 2010;39(3):284-91.
21. Idrees M, Lal A, Malik FA, Hussain A, Rehman I, Akbar H, et al. Occult hepatitis C virus infection and associated predictive factors: the Pakistan experience. Infect Genet Evol. 2011;11(2):442-5.
22. Comar M, Dal Molin G, D'Agaro P, Croce SL, Tiribelli C, Campello C. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin Pathol. 2006;59(5):526-9.
23. De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh V, Palli D, et al. Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One. 2009;4(12).
24. De Marco L, Manzini P, Trevisan M, Gillio-Tos A, Danielle F, Balloco C, et al. Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease. PLoS One. 2012;7(8).
25. Giannini C, Giannelli F, Zignego AL. Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology. 2006;43(5):1166-7.
26. Richiardi L, De Marco L, Gillio-Tos A, Merletti F, Fiano V, Palli D, et al. Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin's lymphoma. Cancer Epidemiol. 2010;34(6):709-12.
27. Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology. 2009;49(2):665-75.
28. Sefidi FJ, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of Hepatitis C Virus Genotypes in Iranian Chronic Infected Patients. Hepatitis Monthly. 2013;13(1).
29. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med. 2007;131(5):702-7.
30. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7.
31. Falagas ME, Karydis I, Kostogiannou I. Percutaneous exposure incidents of the health care personnel in a newly founded tertiary hospital: a prospective study. PLoS One. 2007;2(2).
32. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol. 2009;81(7):1198-203.
33. Melon S, Galarraga MC, Villar M, Laures A, Boga JA, de Ona M, et al. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transplant Proc. 2005;37(5):2083-5.
34. Cortés-Mancera FM, Restrepo JC, Osorio G, Hoyos S, Correa G, MC N. Occult hepatitis C virus infection in a retransplanted patients with liver failure of unknown etiology. Rev Col Gastroenterol. 2010;25:72-80.
35. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol. 2003;41(7):3212-20.
36. Stankovi-Djordjevi D, Tasi G, Dini M, Miladinovi-Tasi N, Stojanovi P, Bogdanovi M. Hepatitis C virus (HCV) viremia in patients with indeterminate second-generation HCV recombinant immunoblot assay. 2007.